Global Epistaxis Device Market

Epistaxis Device Comprehensive Study by Type (Nasal Tampons, Nasal Catheters, Nasal Packing, Others), Application (Anterior Epistaxis, Posterior Epistaxis), End-User (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2030

Epistaxis Device Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Epistaxis Device
Epistaxis is a situation that results in uncertain nose bleeding from either of the nostrils. The epistaxis device consists of the CMC fabric over an inflatable PVC balloon and the nasal dressings have a CMC fabric bag over a special sponge. The dressings are also capable of acting as a drug delivery system. Epistaxis device comprises of nasal packing devices that are used in the treatment and prevention of nosebleeds. The application of epistaxis devices in anterior epistaxis and posterior epistaxis.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


Epistaxis Device is a fragmented market due to the presence of various players. The players are focusing on strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Epistaxis Device market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

DeRoyal Industries Inc. (United States), Medtronic Plc (Ireland), Pfizer Inc. (United States), Smith & Nephew Plc (United Kingdom), Stryker Corp. (United States), Teleflex Inc. (United States), Summit Medical, Inc. (United States), King Pharmaceutical, Inc. (United States), GlaxoSmithKline plc (United Kingdom), Entellus Medical (United States) and Bristol-Myers Squibb Company (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are CogENT Therapeutics (United States) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Epistaxis Device market by Type (Nasal Tampons, Nasal Catheters, Nasal Packing and Others), Application (Anterior Epistaxis and Posterior Epistaxis) and Region.



On the basis of geography, the market of Epistaxis Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-User, the sub-segment i.e. Hospitals will boost the Epistaxis Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technological Advances in Materials of Epistaxis Device Used After Functional Endoscopic Sinus Surgery

Market Growth Drivers:
Rising Cases of Epistaxis, Increase in a Number of Patients with Nasal and Sinus Cancers and Rise in the Prevalence of High BP and Air Pollution

Challenges:
Lack of Awareness about Epistaxis Treatment

Restraints:
Side Effects of Nasal Packing

Opportunities:
Increasing Investment in Healthcare Infrastructure by Developing Countries

Market Leaders and their expansionary development strategies
In June 2019 - Medtronic plc, a global leader in medical technology, announced it has completed the acquisition of Titan Spine, a privately held titanium spine interbody implant and surface technology company. The acquisition of Titan Spine strengthens Medtronic’s position as a leading innovator in procedural solutions for spine surgery.
In May 2019 - Medtronic plc, a global leader in percutaneous coronary intervention (PCI) innovation, announced launch of the Telescope(TM) Guide Extension Catheter, a newly designed catheter used to provide additional backup support and access to distal lesions. Guide extension catheters help deliver coronary stents, balloons and other interventional devices during angioplasty procedures that help to restore blood flow through the coronary and peripheral arteries.


Key Target Audience
Manufacturers of Epistaxis Device, Suppliers of Epistaxis Device, Wholesalers, Distributors and Retailers of Epistaxis Device, Healthcare Industry, Regulatory Bodies and Governmental Bodies

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Nasal Tampons
  • Nasal Catheters
  • Nasal Packing
  • Others
By Application
  • Anterior Epistaxis
  • Posterior Epistaxis
By End-User
  • Hospitals
  • Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Cases of Epistaxis
      • 3.2.2. Increase in a Number of Patients with Nasal and Sinus Cancers
      • 3.2.3. Rise in the Prevalence of High BP and Air Pollution
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness about Epistaxis Treatment
    • 3.4. Market Trends
      • 3.4.1. Technological Advances in Materials of Epistaxis Device Used After Functional Endoscopic Sinus Surgery
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Epistaxis Device, by Type, Application, End-User and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Epistaxis Device (Value)
      • 5.2.1. Global Epistaxis Device by: Type (Value)
        • 5.2.1.1. Nasal Tampons
        • 5.2.1.2. Nasal Catheters
        • 5.2.1.3. Nasal Packing
        • 5.2.1.4. Others
      • 5.2.2. Global Epistaxis Device by: Application (Value)
        • 5.2.2.1. Anterior Epistaxis
        • 5.2.2.2. Posterior Epistaxis
      • 5.2.3. Global Epistaxis Device by: End-User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Others
      • 5.2.4. Global Epistaxis Device Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Epistaxis Device (Volume)
      • 5.3.1. Global Epistaxis Device by: Type (Volume)
        • 5.3.1.1. Nasal Tampons
        • 5.3.1.2. Nasal Catheters
        • 5.3.1.3. Nasal Packing
        • 5.3.1.4. Others
      • 5.3.2. Global Epistaxis Device by: Application (Volume)
        • 5.3.2.1. Anterior Epistaxis
        • 5.3.2.2. Posterior Epistaxis
      • 5.3.3. Global Epistaxis Device by: End-User (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Clinics
        • 5.3.3.3. Others
      • 5.3.4. Global Epistaxis Device Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Epistaxis Device (Price)
      • 5.4.1. Global Epistaxis Device by: Type (Price)
  • 6. Epistaxis Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. DeRoyal Industries Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic Plc (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pfizer Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Smith & Nephew Plc (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Stryker Corp. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Teleflex Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Summit Medical, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. King Pharmaceutical, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. GlaxoSmithKline plc (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Entellus Medical (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Bristol-Myers Squibb Company (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Epistaxis Device Sale, by Type, Application, End-User and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Epistaxis Device (Value)
      • 7.2.1. Global Epistaxis Device by: Type (Value)
        • 7.2.1.1. Nasal Tampons
        • 7.2.1.2. Nasal Catheters
        • 7.2.1.3. Nasal Packing
        • 7.2.1.4. Others
      • 7.2.2. Global Epistaxis Device by: Application (Value)
        • 7.2.2.1. Anterior Epistaxis
        • 7.2.2.2. Posterior Epistaxis
      • 7.2.3. Global Epistaxis Device by: End-User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Others
      • 7.2.4. Global Epistaxis Device Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Epistaxis Device (Volume)
      • 7.3.1. Global Epistaxis Device by: Type (Volume)
        • 7.3.1.1. Nasal Tampons
        • 7.3.1.2. Nasal Catheters
        • 7.3.1.3. Nasal Packing
        • 7.3.1.4. Others
      • 7.3.2. Global Epistaxis Device by: Application (Volume)
        • 7.3.2.1. Anterior Epistaxis
        • 7.3.2.2. Posterior Epistaxis
      • 7.3.3. Global Epistaxis Device by: End-User (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Clinics
        • 7.3.3.3. Others
      • 7.3.4. Global Epistaxis Device Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Epistaxis Device (Price)
      • 7.4.1. Global Epistaxis Device by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Epistaxis Device: by Type(USD Million)
  • Table 2. Epistaxis Device Nasal Tampons , by Region USD Million (2018-2023)
  • Table 3. Epistaxis Device Nasal Catheters , by Region USD Million (2018-2023)
  • Table 4. Epistaxis Device Nasal Packing , by Region USD Million (2018-2023)
  • Table 5. Epistaxis Device Others , by Region USD Million (2018-2023)
  • Table 6. Epistaxis Device: by Application(USD Million)
  • Table 7. Epistaxis Device Anterior Epistaxis , by Region USD Million (2018-2023)
  • Table 8. Epistaxis Device Posterior Epistaxis , by Region USD Million (2018-2023)
  • Table 9. Epistaxis Device: by End-User(USD Million)
  • Table 10. Epistaxis Device Hospitals , by Region USD Million (2018-2023)
  • Table 11. Epistaxis Device Clinics , by Region USD Million (2018-2023)
  • Table 12. Epistaxis Device Others , by Region USD Million (2018-2023)
  • Table 13. South America Epistaxis Device, by Country USD Million (2018-2023)
  • Table 14. South America Epistaxis Device, by Type USD Million (2018-2023)
  • Table 15. South America Epistaxis Device, by Application USD Million (2018-2023)
  • Table 16. South America Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 17. Brazil Epistaxis Device, by Type USD Million (2018-2023)
  • Table 18. Brazil Epistaxis Device, by Application USD Million (2018-2023)
  • Table 19. Brazil Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 20. Argentina Epistaxis Device, by Type USD Million (2018-2023)
  • Table 21. Argentina Epistaxis Device, by Application USD Million (2018-2023)
  • Table 22. Argentina Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 23. Rest of South America Epistaxis Device, by Type USD Million (2018-2023)
  • Table 24. Rest of South America Epistaxis Device, by Application USD Million (2018-2023)
  • Table 25. Rest of South America Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 26. Asia Pacific Epistaxis Device, by Country USD Million (2018-2023)
  • Table 27. Asia Pacific Epistaxis Device, by Type USD Million (2018-2023)
  • Table 28. Asia Pacific Epistaxis Device, by Application USD Million (2018-2023)
  • Table 29. Asia Pacific Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 30. China Epistaxis Device, by Type USD Million (2018-2023)
  • Table 31. China Epistaxis Device, by Application USD Million (2018-2023)
  • Table 32. China Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 33. Japan Epistaxis Device, by Type USD Million (2018-2023)
  • Table 34. Japan Epistaxis Device, by Application USD Million (2018-2023)
  • Table 35. Japan Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 36. India Epistaxis Device, by Type USD Million (2018-2023)
  • Table 37. India Epistaxis Device, by Application USD Million (2018-2023)
  • Table 38. India Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 39. South Korea Epistaxis Device, by Type USD Million (2018-2023)
  • Table 40. South Korea Epistaxis Device, by Application USD Million (2018-2023)
  • Table 41. South Korea Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 42. Taiwan Epistaxis Device, by Type USD Million (2018-2023)
  • Table 43. Taiwan Epistaxis Device, by Application USD Million (2018-2023)
  • Table 44. Taiwan Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 45. Australia Epistaxis Device, by Type USD Million (2018-2023)
  • Table 46. Australia Epistaxis Device, by Application USD Million (2018-2023)
  • Table 47. Australia Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Epistaxis Device, by Type USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Epistaxis Device, by Application USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 51. Europe Epistaxis Device, by Country USD Million (2018-2023)
  • Table 52. Europe Epistaxis Device, by Type USD Million (2018-2023)
  • Table 53. Europe Epistaxis Device, by Application USD Million (2018-2023)
  • Table 54. Europe Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 55. Germany Epistaxis Device, by Type USD Million (2018-2023)
  • Table 56. Germany Epistaxis Device, by Application USD Million (2018-2023)
  • Table 57. Germany Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 58. France Epistaxis Device, by Type USD Million (2018-2023)
  • Table 59. France Epistaxis Device, by Application USD Million (2018-2023)
  • Table 60. France Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 61. Italy Epistaxis Device, by Type USD Million (2018-2023)
  • Table 62. Italy Epistaxis Device, by Application USD Million (2018-2023)
  • Table 63. Italy Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 64. United Kingdom Epistaxis Device, by Type USD Million (2018-2023)
  • Table 65. United Kingdom Epistaxis Device, by Application USD Million (2018-2023)
  • Table 66. United Kingdom Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 67. Netherlands Epistaxis Device, by Type USD Million (2018-2023)
  • Table 68. Netherlands Epistaxis Device, by Application USD Million (2018-2023)
  • Table 69. Netherlands Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 70. Rest of Europe Epistaxis Device, by Type USD Million (2018-2023)
  • Table 71. Rest of Europe Epistaxis Device, by Application USD Million (2018-2023)
  • Table 72. Rest of Europe Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 73. MEA Epistaxis Device, by Country USD Million (2018-2023)
  • Table 74. MEA Epistaxis Device, by Type USD Million (2018-2023)
  • Table 75. MEA Epistaxis Device, by Application USD Million (2018-2023)
  • Table 76. MEA Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 77. Middle East Epistaxis Device, by Type USD Million (2018-2023)
  • Table 78. Middle East Epistaxis Device, by Application USD Million (2018-2023)
  • Table 79. Middle East Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 80. Africa Epistaxis Device, by Type USD Million (2018-2023)
  • Table 81. Africa Epistaxis Device, by Application USD Million (2018-2023)
  • Table 82. Africa Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 83. North America Epistaxis Device, by Country USD Million (2018-2023)
  • Table 84. North America Epistaxis Device, by Type USD Million (2018-2023)
  • Table 85. North America Epistaxis Device, by Application USD Million (2018-2023)
  • Table 86. North America Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 87. United States Epistaxis Device, by Type USD Million (2018-2023)
  • Table 88. United States Epistaxis Device, by Application USD Million (2018-2023)
  • Table 89. United States Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 90. Canada Epistaxis Device, by Type USD Million (2018-2023)
  • Table 91. Canada Epistaxis Device, by Application USD Million (2018-2023)
  • Table 92. Canada Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 93. Mexico Epistaxis Device, by Type USD Million (2018-2023)
  • Table 94. Mexico Epistaxis Device, by Application USD Million (2018-2023)
  • Table 95. Mexico Epistaxis Device, by End-User USD Million (2018-2023)
  • Table 96. Epistaxis Device Sales: by Type(K Units)
  • Table 97. Epistaxis Device Sales Nasal Tampons , by Region K Units (2018-2023)
  • Table 98. Epistaxis Device Sales Nasal Catheters , by Region K Units (2018-2023)
  • Table 99. Epistaxis Device Sales Nasal Packing , by Region K Units (2018-2023)
  • Table 100. Epistaxis Device Sales Others , by Region K Units (2018-2023)
  • Table 101. Epistaxis Device Sales: by Application(K Units)
  • Table 102. Epistaxis Device Sales Anterior Epistaxis , by Region K Units (2018-2023)
  • Table 103. Epistaxis Device Sales Posterior Epistaxis , by Region K Units (2018-2023)
  • Table 104. Epistaxis Device Sales: by End-User(K Units)
  • Table 105. Epistaxis Device Sales Hospitals , by Region K Units (2018-2023)
  • Table 106. Epistaxis Device Sales Clinics , by Region K Units (2018-2023)
  • Table 107. Epistaxis Device Sales Others , by Region K Units (2018-2023)
  • Table 108. South America Epistaxis Device Sales, by Country K Units (2018-2023)
  • Table 109. South America Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 110. South America Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 111. South America Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 112. Brazil Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 113. Brazil Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 114. Brazil Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 115. Argentina Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 116. Argentina Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 117. Argentina Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 118. Rest of South America Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 119. Rest of South America Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 120. Rest of South America Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 121. Asia Pacific Epistaxis Device Sales, by Country K Units (2018-2023)
  • Table 122. Asia Pacific Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 123. Asia Pacific Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 124. Asia Pacific Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 125. China Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 126. China Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 127. China Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 128. Japan Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 129. Japan Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 130. Japan Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 131. India Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 132. India Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 133. India Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 134. South Korea Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 135. South Korea Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 136. South Korea Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 137. Taiwan Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 138. Taiwan Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 139. Taiwan Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 140. Australia Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 141. Australia Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 142. Australia Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 143. Rest of Asia-Pacific Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 144. Rest of Asia-Pacific Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 145. Rest of Asia-Pacific Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 146. Europe Epistaxis Device Sales, by Country K Units (2018-2023)
  • Table 147. Europe Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 148. Europe Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 149. Europe Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 150. Germany Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 151. Germany Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 152. Germany Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 153. France Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 154. France Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 155. France Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 156. Italy Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 157. Italy Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 158. Italy Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 159. United Kingdom Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 160. United Kingdom Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 161. United Kingdom Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 162. Netherlands Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 163. Netherlands Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 164. Netherlands Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 165. Rest of Europe Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 166. Rest of Europe Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 167. Rest of Europe Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 168. MEA Epistaxis Device Sales, by Country K Units (2018-2023)
  • Table 169. MEA Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 170. MEA Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 171. MEA Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 172. Middle East Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 173. Middle East Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 174. Middle East Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 175. Africa Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 176. Africa Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 177. Africa Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 178. North America Epistaxis Device Sales, by Country K Units (2018-2023)
  • Table 179. North America Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 180. North America Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 181. North America Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 182. United States Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 183. United States Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 184. United States Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 185. Canada Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 186. Canada Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 187. Canada Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 188. Mexico Epistaxis Device Sales, by Type K Units (2018-2023)
  • Table 189. Mexico Epistaxis Device Sales, by Application K Units (2018-2023)
  • Table 190. Mexico Epistaxis Device Sales, by End-User K Units (2018-2023)
  • Table 191. Epistaxis Device: by Type(USD/Units)
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Epistaxis Device: by Type(USD Million)
  • Table 204. Epistaxis Device Nasal Tampons , by Region USD Million (2025-2030)
  • Table 205. Epistaxis Device Nasal Catheters , by Region USD Million (2025-2030)
  • Table 206. Epistaxis Device Nasal Packing , by Region USD Million (2025-2030)
  • Table 207. Epistaxis Device Others , by Region USD Million (2025-2030)
  • Table 208. Epistaxis Device: by Application(USD Million)
  • Table 209. Epistaxis Device Anterior Epistaxis , by Region USD Million (2025-2030)
  • Table 210. Epistaxis Device Posterior Epistaxis , by Region USD Million (2025-2030)
  • Table 211. Epistaxis Device: by End-User(USD Million)
  • Table 212. Epistaxis Device Hospitals , by Region USD Million (2025-2030)
  • Table 213. Epistaxis Device Clinics , by Region USD Million (2025-2030)
  • Table 214. Epistaxis Device Others , by Region USD Million (2025-2030)
  • Table 215. South America Epistaxis Device, by Country USD Million (2025-2030)
  • Table 216. South America Epistaxis Device, by Type USD Million (2025-2030)
  • Table 217. South America Epistaxis Device, by Application USD Million (2025-2030)
  • Table 218. South America Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 219. Brazil Epistaxis Device, by Type USD Million (2025-2030)
  • Table 220. Brazil Epistaxis Device, by Application USD Million (2025-2030)
  • Table 221. Brazil Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 222. Argentina Epistaxis Device, by Type USD Million (2025-2030)
  • Table 223. Argentina Epistaxis Device, by Application USD Million (2025-2030)
  • Table 224. Argentina Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 225. Rest of South America Epistaxis Device, by Type USD Million (2025-2030)
  • Table 226. Rest of South America Epistaxis Device, by Application USD Million (2025-2030)
  • Table 227. Rest of South America Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 228. Asia Pacific Epistaxis Device, by Country USD Million (2025-2030)
  • Table 229. Asia Pacific Epistaxis Device, by Type USD Million (2025-2030)
  • Table 230. Asia Pacific Epistaxis Device, by Application USD Million (2025-2030)
  • Table 231. Asia Pacific Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 232. China Epistaxis Device, by Type USD Million (2025-2030)
  • Table 233. China Epistaxis Device, by Application USD Million (2025-2030)
  • Table 234. China Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 235. Japan Epistaxis Device, by Type USD Million (2025-2030)
  • Table 236. Japan Epistaxis Device, by Application USD Million (2025-2030)
  • Table 237. Japan Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 238. India Epistaxis Device, by Type USD Million (2025-2030)
  • Table 239. India Epistaxis Device, by Application USD Million (2025-2030)
  • Table 240. India Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 241. South Korea Epistaxis Device, by Type USD Million (2025-2030)
  • Table 242. South Korea Epistaxis Device, by Application USD Million (2025-2030)
  • Table 243. South Korea Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 244. Taiwan Epistaxis Device, by Type USD Million (2025-2030)
  • Table 245. Taiwan Epistaxis Device, by Application USD Million (2025-2030)
  • Table 246. Taiwan Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 247. Australia Epistaxis Device, by Type USD Million (2025-2030)
  • Table 248. Australia Epistaxis Device, by Application USD Million (2025-2030)
  • Table 249. Australia Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 250. Rest of Asia-Pacific Epistaxis Device, by Type USD Million (2025-2030)
  • Table 251. Rest of Asia-Pacific Epistaxis Device, by Application USD Million (2025-2030)
  • Table 252. Rest of Asia-Pacific Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 253. Europe Epistaxis Device, by Country USD Million (2025-2030)
  • Table 254. Europe Epistaxis Device, by Type USD Million (2025-2030)
  • Table 255. Europe Epistaxis Device, by Application USD Million (2025-2030)
  • Table 256. Europe Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 257. Germany Epistaxis Device, by Type USD Million (2025-2030)
  • Table 258. Germany Epistaxis Device, by Application USD Million (2025-2030)
  • Table 259. Germany Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 260. France Epistaxis Device, by Type USD Million (2025-2030)
  • Table 261. France Epistaxis Device, by Application USD Million (2025-2030)
  • Table 262. France Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 263. Italy Epistaxis Device, by Type USD Million (2025-2030)
  • Table 264. Italy Epistaxis Device, by Application USD Million (2025-2030)
  • Table 265. Italy Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 266. United Kingdom Epistaxis Device, by Type USD Million (2025-2030)
  • Table 267. United Kingdom Epistaxis Device, by Application USD Million (2025-2030)
  • Table 268. United Kingdom Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 269. Netherlands Epistaxis Device, by Type USD Million (2025-2030)
  • Table 270. Netherlands Epistaxis Device, by Application USD Million (2025-2030)
  • Table 271. Netherlands Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 272. Rest of Europe Epistaxis Device, by Type USD Million (2025-2030)
  • Table 273. Rest of Europe Epistaxis Device, by Application USD Million (2025-2030)
  • Table 274. Rest of Europe Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 275. MEA Epistaxis Device, by Country USD Million (2025-2030)
  • Table 276. MEA Epistaxis Device, by Type USD Million (2025-2030)
  • Table 277. MEA Epistaxis Device, by Application USD Million (2025-2030)
  • Table 278. MEA Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 279. Middle East Epistaxis Device, by Type USD Million (2025-2030)
  • Table 280. Middle East Epistaxis Device, by Application USD Million (2025-2030)
  • Table 281. Middle East Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 282. Africa Epistaxis Device, by Type USD Million (2025-2030)
  • Table 283. Africa Epistaxis Device, by Application USD Million (2025-2030)
  • Table 284. Africa Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 285. North America Epistaxis Device, by Country USD Million (2025-2030)
  • Table 286. North America Epistaxis Device, by Type USD Million (2025-2030)
  • Table 287. North America Epistaxis Device, by Application USD Million (2025-2030)
  • Table 288. North America Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 289. United States Epistaxis Device, by Type USD Million (2025-2030)
  • Table 290. United States Epistaxis Device, by Application USD Million (2025-2030)
  • Table 291. United States Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 292. Canada Epistaxis Device, by Type USD Million (2025-2030)
  • Table 293. Canada Epistaxis Device, by Application USD Million (2025-2030)
  • Table 294. Canada Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 295. Mexico Epistaxis Device, by Type USD Million (2025-2030)
  • Table 296. Mexico Epistaxis Device, by Application USD Million (2025-2030)
  • Table 297. Mexico Epistaxis Device, by End-User USD Million (2025-2030)
  • Table 298. Epistaxis Device Sales: by Type(K Units)
  • Table 299. Epistaxis Device Sales Nasal Tampons , by Region K Units (2025-2030)
  • Table 300. Epistaxis Device Sales Nasal Catheters , by Region K Units (2025-2030)
  • Table 301. Epistaxis Device Sales Nasal Packing , by Region K Units (2025-2030)
  • Table 302. Epistaxis Device Sales Others , by Region K Units (2025-2030)
  • Table 303. Epistaxis Device Sales: by Application(K Units)
  • Table 304. Epistaxis Device Sales Anterior Epistaxis , by Region K Units (2025-2030)
  • Table 305. Epistaxis Device Sales Posterior Epistaxis , by Region K Units (2025-2030)
  • Table 306. Epistaxis Device Sales: by End-User(K Units)
  • Table 307. Epistaxis Device Sales Hospitals , by Region K Units (2025-2030)
  • Table 308. Epistaxis Device Sales Clinics , by Region K Units (2025-2030)
  • Table 309. Epistaxis Device Sales Others , by Region K Units (2025-2030)
  • Table 310. South America Epistaxis Device Sales, by Country K Units (2025-2030)
  • Table 311. South America Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 312. South America Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 313. South America Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 314. Brazil Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 315. Brazil Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 316. Brazil Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 317. Argentina Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 318. Argentina Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 319. Argentina Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 320. Rest of South America Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 321. Rest of South America Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 322. Rest of South America Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 323. Asia Pacific Epistaxis Device Sales, by Country K Units (2025-2030)
  • Table 324. Asia Pacific Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 325. Asia Pacific Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 326. Asia Pacific Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 327. China Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 328. China Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 329. China Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 330. Japan Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 331. Japan Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 332. Japan Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 333. India Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 334. India Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 335. India Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 336. South Korea Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 337. South Korea Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 338. South Korea Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 339. Taiwan Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 340. Taiwan Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 341. Taiwan Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 342. Australia Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 343. Australia Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 344. Australia Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 345. Rest of Asia-Pacific Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 346. Rest of Asia-Pacific Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 347. Rest of Asia-Pacific Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 348. Europe Epistaxis Device Sales, by Country K Units (2025-2030)
  • Table 349. Europe Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 350. Europe Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 351. Europe Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 352. Germany Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 353. Germany Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 354. Germany Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 355. France Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 356. France Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 357. France Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 358. Italy Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 359. Italy Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 360. Italy Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 361. United Kingdom Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 362. United Kingdom Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 363. United Kingdom Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 364. Netherlands Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 365. Netherlands Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 366. Netherlands Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 367. Rest of Europe Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 368. Rest of Europe Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 369. Rest of Europe Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 370. MEA Epistaxis Device Sales, by Country K Units (2025-2030)
  • Table 371. MEA Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 372. MEA Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 373. MEA Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 374. Middle East Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 375. Middle East Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 376. Middle East Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 377. Africa Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 378. Africa Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 379. Africa Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 380. North America Epistaxis Device Sales, by Country K Units (2025-2030)
  • Table 381. North America Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 382. North America Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 383. North America Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 384. United States Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 385. United States Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 386. United States Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 387. Canada Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 388. Canada Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 389. Canada Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 390. Mexico Epistaxis Device Sales, by Type K Units (2025-2030)
  • Table 391. Mexico Epistaxis Device Sales, by Application K Units (2025-2030)
  • Table 392. Mexico Epistaxis Device Sales, by End-User K Units (2025-2030)
  • Table 393. Epistaxis Device: by Type(USD/Units)
  • Table 394. Research Programs/Design for This Report
  • Table 395. Key Data Information from Secondary Sources
  • Table 396. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Epistaxis Device: by Type USD Million (2018-2023)
  • Figure 5. Global Epistaxis Device: by Application USD Million (2018-2023)
  • Figure 6. Global Epistaxis Device: by End-User USD Million (2018-2023)
  • Figure 7. South America Epistaxis Device Share (%), by Country
  • Figure 8. Asia Pacific Epistaxis Device Share (%), by Country
  • Figure 9. Europe Epistaxis Device Share (%), by Country
  • Figure 10. MEA Epistaxis Device Share (%), by Country
  • Figure 11. North America Epistaxis Device Share (%), by Country
  • Figure 12. Global Epistaxis Device: by Type K Units (2018-2023)
  • Figure 13. Global Epistaxis Device: by Application K Units (2018-2023)
  • Figure 14. Global Epistaxis Device: by End-User K Units (2018-2023)
  • Figure 15. South America Epistaxis Device Share (%), by Country
  • Figure 16. Asia Pacific Epistaxis Device Share (%), by Country
  • Figure 17. Europe Epistaxis Device Share (%), by Country
  • Figure 18. MEA Epistaxis Device Share (%), by Country
  • Figure 19. North America Epistaxis Device Share (%), by Country
  • Figure 20. Global Epistaxis Device: by Type USD/Units (2018-2023)
  • Figure 21. Global Epistaxis Device share by Players 2023 (%)
  • Figure 22. Global Epistaxis Device share by Players (Top 3) 2023(%)
  • Figure 23. Global Epistaxis Device share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. DeRoyal Industries Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. DeRoyal Industries Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Medtronic Plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 28. Medtronic Plc (Ireland) Revenue: by Geography 2023
  • Figure 29. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Pfizer Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Smith & Nephew Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Smith & Nephew Plc (United Kingdom) Revenue: by Geography 2023
  • Figure 33. Stryker Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Stryker Corp. (United States) Revenue: by Geography 2023
  • Figure 35. Teleflex Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Teleflex Inc. (United States) Revenue: by Geography 2023
  • Figure 37. Summit Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Summit Medical, Inc. (United States) Revenue: by Geography 2023
  • Figure 39. King Pharmaceutical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. King Pharmaceutical, Inc. (United States) Revenue: by Geography 2023
  • Figure 41. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 42. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2023
  • Figure 43. Entellus Medical (United States) Revenue, Net Income and Gross profit
  • Figure 44. Entellus Medical (United States) Revenue: by Geography 2023
  • Figure 45. Bristol-Myers Squibb Company (United States) Revenue, Net Income and Gross profit
  • Figure 46. Bristol-Myers Squibb Company (United States) Revenue: by Geography 2023
  • Figure 47. Global Epistaxis Device: by Type USD Million (2025-2030)
  • Figure 48. Global Epistaxis Device: by Application USD Million (2025-2030)
  • Figure 49. Global Epistaxis Device: by End-User USD Million (2025-2030)
  • Figure 50. South America Epistaxis Device Share (%), by Country
  • Figure 51. Asia Pacific Epistaxis Device Share (%), by Country
  • Figure 52. Europe Epistaxis Device Share (%), by Country
  • Figure 53. MEA Epistaxis Device Share (%), by Country
  • Figure 54. North America Epistaxis Device Share (%), by Country
  • Figure 55. Global Epistaxis Device: by Type K Units (2025-2030)
  • Figure 56. Global Epistaxis Device: by Application K Units (2025-2030)
  • Figure 57. Global Epistaxis Device: by End-User K Units (2025-2030)
  • Figure 58. South America Epistaxis Device Share (%), by Country
  • Figure 59. Asia Pacific Epistaxis Device Share (%), by Country
  • Figure 60. Europe Epistaxis Device Share (%), by Country
  • Figure 61. MEA Epistaxis Device Share (%), by Country
  • Figure 62. North America Epistaxis Device Share (%), by Country
  • Figure 63. Global Epistaxis Device: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • DeRoyal Industries Inc. (United States)
  • Medtronic Plc (Ireland)
  • Pfizer Inc. (United States)
  • Smith & Nephew Plc (United Kingdom)
  • Stryker Corp. (United States)
  • Teleflex Inc. (United States)
  • Summit Medical, Inc. (United States)
  • King Pharmaceutical, Inc. (United States)
  • GlaxoSmithKline plc (United Kingdom)
  • Entellus Medical (United States)
  • Bristol-Myers Squibb Company (United States)
Additional players considered in the study are as follows:
CogENT Therapeutics (United States) , Others
Select User Access Type

Key Highlights of Report


Jan 2024 202 Pages 74 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Epistaxis Device Market Quantitative research analysis
Global Epistaxis Device Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as DeRoyal Industries Inc. (United States), Medtronic Plc (Ireland), Pfizer Inc. (United States), Smith & Nephew Plc (United Kingdom), Stryker Corp. (United States), Teleflex Inc. (United States), Summit Medical, Inc. (United States), King Pharmaceutical, Inc. (United States), GlaxoSmithKline plc (United Kingdom), Entellus Medical (United States) and Bristol-Myers Squibb Company (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technological Advances in Materials of Epistaxis Device Used After Functional Endoscopic Sinus Surgery" is seen as one of major influencing trends for Epistaxis Device Market during projected period 2023-2030.
The Epistaxis Device market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Epistaxis Device Market Report?

Have a Query? Click Here

Other Related Reports

Suture Anchor Devices Comprehensive Study by Type (Absorbable, Non-Absorbable), Application (Hospitals, Clinics, Ambulatory Surgical Centres, Emergency Medical Services, Others), Tying Type (Knotted ...
$ 3750
Veterinary Chemistry Analyzers Comprehensive Study by Type (Automatic, Semi-Automatic), Application (Hospital, Clinical, Path Lab, Research), Modes (Five-part, Four-part, Three-part), Configuration (...
$ 3450
Non Woven Face Mask Comprehensive Study by Type (1 Ply, 2 Ply, 3 Ply), Application (Hospitals, Dental, Clean Room, Food Preparation, Industrial Environment), Distribution Channel (Hospitals, Clinics,...
$ 3450
Interspinous Spacers Comprehensive Study by Type (Static, Dynamic), Material Used (Bone, Metal, Synthetics), End User (Hospitals, Ambulatory Surgery Centers, Orthopedic Clinics), Static Devices (X ST...
$ 3350
Antiseptic And Disinfectant Comprehensive Study by Type (Disinfectants, Antiseptics), Application (Hygiene, Food and Feed, Drinking-Water, Medical Device and Stuff) Players and Region - Global Market...
$ 3500
Transport Stretchers Comprehensive Study by Type (Fixed Stretchers, Adjustable Stretchers, Stretcher Chairs), Sales Channel (Direct, Indirect) Players and Region - Global Market Outlook to 2026
$ 3500